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Technology: Competitive & Complementary 
Silicon based biochips 
Iuf ineon has launched Flow- 
Thru biochips and a matching 
complete analysis ystem, with 
US partner  MetriGenix. 
"We went  from a skunkworks 
operation to a mass-market 
introduct ion in only two 
month," reflects Robert LeFort, 
president of Inf ineon 
Technologies North America 
Corp, who  noted there was a 
clear business case to be made 
for DNA analysis chips. 
"With test tubes, you have a 
serial, one-at-a-time system. But 
with a DNA analysis chip, you 
can do 128 trials at a t ime with 
far less reagent." 
The biochips are miniatur ised 
sample sil icon substrates,  on 
wh ich  hundreds  of  s imultane- 
ous b iomolecular  tests can be 
per formed using optical evalu- 
at ion.The biochip uses a 3D 
micro-array - a network  of fine 
micro-channels  that run 
between the upper  and the 
lower side of  the chip. 
Traditional p lanar biochips on 
glass substrates only have a 2D 
sensor  surface.With FTC the 
micro-channels  of the biochip 
are prepared by MetriGenix, 
wh ich  populates  the chip with 
segments  of  known genes that 
fix themselves  on the walls of  
the micro-channels.  
The gene sample to be 
analysed is repeatedly pumped 
back and forth th rough the 
pore, causing match ing  genes 
FlowThru biochip using 3D microarrajz Etched channel structures mean more 
molecules can react with each other, increasing sensitivitjz 
of the sample to bind wi th  
known genes on the pore wall. 
A luminescent  dye binds wi th  
the matched  gene segments .  
Its l ight is captured by a 
CCD camera and forwarded 
to computer .  An etch process  
creates about  lmn 
channe ls /cm 2 of chip surface, 
each wi th  a d iameter  of  10 
microns and a depth  of  
0 .5mm. About  100 of 
these channels  are used 
per  probe molecule,  each 
chip typically being 
conf igured wi th  100 to 400 
probe molecules  or gene 
sect ions (spots) .The 
techn ique  means  that the 
react ion speed dur ing 
hybridisat ion is no longer 
dependent  on the time-con- 
suming  diffusion process  used 
by planar biochips. Owing to a 
channel  structure,  a hundred  
t imes more  molecu les  can 
react wi th  each other, increas- 
ing sensitivity. 
Nanotechnology,  VLSI 
fabrication, genet ic engineer-  
ing and drug design are all 
intersect ing in the rapidly 
developing field of  BioMEMS, 
where  chip makers  are 
eyeing BioMEMS research 
deve lopments  as a supp lement  
to the oversuppl ied electronics 
market.  By further  developing 
exist ing semiconductor  
technologies,  Inf ineon will 
develop and produce  cost- 
effective chip-based solut ions 
in the field of  biotechnology," 
said Dr .Thomas Klaue, 
director of bus iness  develop- 
ment  and the manager  espon- 
sible for Inf ineon's  b iochip 
activities. 
A number  of specific assays, 
equ ipped with the appropriate 
gene structures for specific dis- 
eases, are available for the com- 
plete "4D Array System" devel- 
oped by Inf ineon and Metri- 
Genix. This compr ises arrays 
for examinat ions for lung and 
breast cancer, t issue prolifera- 
tion, and inf lammation, as well 
as an array for the detect ion of 
neural changes that are the 
cause of  diseases uch as 
Alzheimer's, Parkinson's or 
Multiple Sclerosis. In addition, 
custom arrays are avaiIable that 
provide specific genes with 
complexit ies of 50 to 192 sam- 
ples based on customer  specifi- 
cations. Inf ineon is also devel- 
oping an electronic-based DNA 
chip scheduled for release into 
the market in several years 
time. A third technology, 
Inf ineon's Neuro-Chip is still in 
research phase. 
CDT sells first LEP display products 
The 1.7-inch diagonal, 5x7 pLxel 
segmented isplay module uses 
a yellow polymer with an oper- 
ational ifetime to half lumi- 
nance of 20,000 hours  from an 
initial br ightness of 250 cd /m 
(2). CDT plans to increase the 
product  range by offering dis- 
plays in a variety of colours, 
sizes and configurations for 
diverse industrial, transportation 
and electronics equipment  mar- 
kets. First sh ipment  went  to 
Trident Displays, active in the 
passenger information display 
market where  CDT's LEP dis- 
plays offer wide viewing angles, 
high br ightness and low power  
consumpt ion.  
CDT's manufacturing technology 
development centre began initial 
operation in January 2002 based 
on $25m investment. Since start- 
up, CDT has commissioned 
equipment from major suppliers 
such as Tokki, Ulvac and SSEC, 
and ramped-up operations for 
LEP manufacturing technology 
development using 350ram by 
350mm glass substrates. 
Next generation transistor 
AMD researchers claim to be 
the first in the semiconductor  
industry to achieve critical 
research miIestones for next- 
generat ion transistor develop- 
ment .Among the achievements  
in the laboratory is a high-per- 
formance transistor that is up 
to 30% faster than the best-pub- 
l ished PMOS (P-channel metal- 
oxide semiconductor)  transis- 
tor.The transistor employs pro- 
prietary technologies involving 
fully depleted silicon-on-insula- 
tor structures. 
Related research as demon-  
strated a strained silicon transis- 
tor achieving 20-25% higher  
per formance than conventional  
strained silicon devices through 
the use of  metal gates, also 
claimed as a first. 
These achievements are expect- 
ed byAMD to play a critical role 
in semiconductor  manufacturing 
in the second half of this dec- 
ade. Both will be presented at 
this year's VLSI Symposium, June 
11-12, 2003, in Kyoto, Japan. 
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